About the Authors
- Maria Tsoli
-
Affiliations Experimental Therapeutics, Children’s Cancer Institute for Medical Research, Randwick, NSW, Australia, Cancer Pharmacology Unit, Anzac Research Institute, Concord Repatriation General Hospital, Concord West, NSW, Australia
- Martina Schweiger
-
Affiliation Institute of Molecular Biosciences, University of Graz, Graz, Austria
- Anne S. Vanniasinghe
-
Affiliations Experimental Therapeutics, Children’s Cancer Institute for Medical Research, Randwick, NSW, Australia, Cancer Pharmacology Unit, Anzac Research Institute, Concord Repatriation General Hospital, Concord West, NSW, Australia
- Arran Painter
-
Affiliation Cancer Pharmacology Unit, Anzac Research Institute, Concord Repatriation General Hospital, Concord West, NSW, Australia
- Rudolf Zechner
-
Affiliation Institute of Molecular Biosciences, University of Graz, Graz, Austria
- Stephen Clarke
-
Affiliation Northern Clinical School, University of Sydney, Royal North Shore Hospital, St Leonards, NSW, Australia
- Graham Robertson
-
* E-mail: g.robertson@garvan.org.au
Affiliations Cancer Pharmacology Unit, Anzac Research Institute, Concord Repatriation General Hospital, Concord West, NSW, Australia, Tumorkine Research, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
Competing Interests
Cachectic Colon 26 cells were kindly provided by AMGEN. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MT MS RZ SC GR. Performed the experiments: MT MS AV AP GR. Analyzed the data: MT MS GR. Wrote the paper: MT MS AV AP RZ SC GR.